Another drug has been linked to birth defects.
Epilepsy Drug, Lamictal, linked to birth defects
According to published reports in Canada, an anti-epilepsy drug, LAMICTAL has been linked to oral birth defects in babies born to mothers who took the medication.
In a statement issued by the drug’s maker, GlaxoSmithKline, after discussions with Health Canada, company officials say that pregnant women taking Lamictal (lamotrigine) in the first three months of a pregnancy run an increased risk of baby being born with a cleft lip and/or palate.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.